CVE-2026-0994
Multiple vulnerabilities have been discovered in IBM products. Some of them allow an attacker to cause remote arbitrary code execution, privilege escalation and remote denial of service.
CSIRTS triage
- What
- Multiple vulnerabilities in IBM products including remote code execution, privilege escalation, and denial of service flaws.
- Who is affected
- Multiple IBM product lines are affected; specific products and versions not detailed in advisory.
- Urgency
- High; RCE vulnerabilities warrant immediate remediation across affected IBM products.
- Action
- Identify affected IBM products in your environment and apply relevant patches from IBM security updates.
AI-assisted analysis generated from the source advisory — verify against the original.
⚡ Watch CVE-2026-0994
Get an email if CVE-2026-0994 is added to CISA KEV, gains public exploit code, or a new advisory cites it — max one per day, one-click unsubscribe.
Exploitation outlook
- Low exploitation risk0.69% 30-day exploitation probability — currently an unlikely target, but scores change as exploit code circulates. Riskier than 50% of all EPSS-scored CVEs.
Advisory coverage (2)
- unknownMultiple vulnerabilities in IBM products (July 31, 2026)cert-fr-avis · 2026-07-31
- unknownMultiple vulnerabilities in IBM products (June 26, 2026)cert-fr-avis · 2026-06-26
External references
Embed the live status
— this badge updates automatically when the KEV or exploit status changes. How to embed it →
[](https://www.csirts.com/cve/CVE-2026-0994)